Your browser doesn't support javascript.
loading
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
Sandborn, William J; Feagan, Brian G; Marano, Colleen; Zhang, Hongyan; Strauss, Richard; Johanns, Jewel; Adedokun, Omoniyi J; Guzzo, Cynthia; Colombel, Jean-Frederic; Reinisch, Walter; Gibson, Peter R; Collins, Judith; Järnerot, Gunnar; Hibi, Toshifumi; Rutgeerts, Paul.
Afiliación
  • Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, California. Electronic address: wsandborn@ucsd.edu.
  • Feagan BG; Robarts Research Institute, University of Western Ontario, London, Ontario, Canada.
  • Marano C; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Zhang H; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Strauss R; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Johanns J; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Adedokun OJ; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Guzzo C; Janssen Services, LLC, Horsham, Pennsylvania.
  • Colombel JF; Department of Hepatogastroenterology and Centre D'Investigation Clinique Chu Lille, Université Lille Nord De France, Lille, France; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Reinisch W; Department of Gastroenterology and Hepatology, Universitätsklinik für Innere Medizin III, Vienna, Austria.
  • Gibson PR; Department of Gastroenterology, Monash University, Alfred Hospital, Melbourne, Victoria, Australia.
  • Collins J; Division of Gastroenterology, Department of Medicine, Oregon Health Sciences University, Portland, Oregon.
  • Järnerot G; Division of Gastroenterology, Department of Medicine, Örebro University Hospital, Örebro, Sweden.
  • Hibi T; Department of Internal Medicine, School of Medicine, Keio University, Minato, Tokyo, Japan.
  • Rutgeerts P; Department of Gastroenterology, University Hospital, Gasthuisberg, Leuven, Belgium.
Gastroenterology ; 146(1): 85-95; quiz e14-5, 2014 Jan.
Article en En | MEDLINE | ID: mdl-23735746
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Factor de Necrosis Tumoral alfa / Inmunosupresores / Antiinflamatorios / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Año: 2014 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Factor de Necrosis Tumoral alfa / Inmunosupresores / Antiinflamatorios / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Año: 2014 Tipo del documento: Article